Merck
MRK
#48
Rank
A$460.44 B
Marketcap
A$186.43
Share price
2.56%
Change (1 day)
53.96%
Change (1 year)

Merck (MRK) - Cash on Hand

Cash on Hand as of March 2026 : A$8.26 Billion

According to Merck's latest financial reports the company has A$8.26 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Merck - Cash on Hand chart (from 1996 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$21.74 B-1.19%
2024-12-31A$22.00 B111.39%
2023-12-31A$10.41 B-46.3%
2022-12-31A$19.38 B73.59%
2021-12-31A$11.16 B6.67%
2020-12-31A$10.46 B-29.86%
2019-12-31A$14.92 B18.62%
2018-12-31A$12.58 B15.59%
2017-12-31A$10.88 B-45.29%
2016-12-31A$19.89 B7.94%
2015-12-31A$18.43 B-4.04%
2014-12-31A$19.20 B-2.02%
2013-12-31A$19.60 B26.21%
2012-12-31A$15.53 B6.37%
2011-12-31A$14.60 B21.57%
2010-12-31A$12.01 B12.35%
2009-12-31A$10.69 B37.48%
2008-12-31A$7.77 B-17.4%
2007-12-31A$9.41 B-14.82%
2006-12-31A$11.05 B-48.28%
2005-12-31A$21.37 B133.27%
2004-12-31A$9.16 B63.19%
2003-12-31A$5.61 B-36.37%
2002-12-31A$8.82 B37.01%
2001-12-31A$6.43 B-15.37%
2000-12-31A$7.60 B56.14%
1999-12-31A$4.87 B14.5%
1998-12-31A$4.25 B146.47%
1997-12-31A$1.72 B1.44%
1996-12-31A$1.70 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
A$31.95 B 286.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$10.10 B 22.36%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$18.94 B 129.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$10.57 B 27.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$7.65 B-7.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$17.44 B 111.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$9.29 B 12.53%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
A$15.19 B 83.90%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$6.60 B-20.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$5.42 B-34.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel